Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Avalo Therapeutics (C6K0.F) Q1 2025 Earnings
C6K0.F
20
Mar
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-130.63
-87.14
-43.65
-0.16
Details
Expected EPS
-0.15504310965
Actual EPS
-2.1184149999999997
Surprise EPS
-1.96
Surprise Percent
+1,266.34%
Description
Avalo Therapeutics (C6K0.F) has reported earnings of -2.1184149999999997 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login